These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6151615)
1. [Differential use of beta-blockers in diseases of the cardiovascular system]. Janezic A Lijec Vjesn; 1984; 106(11-12):489. PubMed ID: 6151615 [No Abstract] [Full Text] [Related]
2. [Selection criteria for differential therapy with beta receptor blockers]. Knauf H; Mutschler E; Palm D Dtsch Med Wochenschr; 1990 Dec; 115(51-52):1963-70. PubMed ID: 1979770 [No Abstract] [Full Text] [Related]
3. [The present status and prospects of therapeutic use of beta-blockers in diseases of the cardiovascular system]. Kuzelová M; Svec P Ceska Slov Farm; 1998 Feb; 47(1):4-9. PubMed ID: 9600149 [TBL] [Abstract][Full Text] [Related]
4. [Beta-adreno-blockers use in combination of cardiovascular and pulmonary diseases]. Makolkin VI; Ovcharenko SI; Litvinova IV Ter Arkh; 2008; 80(8):86-9. PubMed ID: 18807550 [No Abstract] [Full Text] [Related]
5. The road ahead with beta-blockers: expanding treatment options in cardiovascular disease. Hollenberg NK Am J Hypertens; 2005 Dec; 18(12 Pt 2):163S-164S. PubMed ID: 16373193 [No Abstract] [Full Text] [Related]
11. The place of beta-blockers in cardiovascular medicine. Cruickshank JM Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060 [No Abstract] [Full Text] [Related]
12. Underuse of beta-blockers in cardiovascular medicine. Gottlieb SS Am J Manag Care; 2000 Apr; 6(6 Suppl):S299-302. PubMed ID: 11010424 [No Abstract] [Full Text] [Related]
13. Prescription drugs uses and effect. Beta blockers. Cardiovascular disease. Jordan S; Knight J Nurs Stand; 2004 Aug 18-24; 18(49):suppl 1-2. PubMed ID: 15478259 [No Abstract] [Full Text] [Related]
14. [Are beta-blockers really depressogenic?]. Pélissolo A; Héloire F Ann Med Psychol (Paris); 1995; 153(7):441-7. PubMed ID: 8526331 [TBL] [Abstract][Full Text] [Related]
19. Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action. Frishman WH Am J Manag Care; 2002 Jun; 8(9 Suppl):13-7. PubMed ID: 12099323 [No Abstract] [Full Text] [Related]
20. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade. Bell DS Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]